시장보고서
상품코드
1828944

세포 및 유전자 치료 공급망 소프트웨어 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 컴포넌트, 용도, 프로세스, 전개, 최종사용자, 스테이지

Cell and Gene Therapy Supply Chain Software Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Process, Deployment, End User, Stage

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 328 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포 및 유전자 치료 공급망 소프트웨어 시장은 2024년 4억 5,820만 달러에서 2034년 20억 2,810만 달러로 확대될 것으로 예상되며, 연평균 약 16%의 성장률을 보일 것으로 전망됩니다. 세포 및 유전자 치료 공급망 소프트웨어 시장에는 첨단 치료의 복잡한 물류를 관리하기 위해 설계된 디지털 솔루션이 포함됩니다. 이러한 플랫폼은 제조부터 환자 손에 닿기까지 컴플라이언스, 추적성, 효율성을 보장합니다. 세포 및 유전자 치료 분야가 확대됨에 따라 개인 맞춤형 의료의 물류, 규제 준수, 실시간 데이터 관리에 대한 정확성이 요구됨에 따라 견고하고 안전하며 확장성이 뛰어난 소프트웨어 솔루션에 대한 수요가 증가하고 있습니다.

세포 및 유전자 치료 공급망 소프트웨어 시장은 개인 맞춤형 의료와 첨단 치료법의 채택 증가로 인해 강력한 성장세를 보이고 있습니다. 소프트웨어 분야, 특히 물류 관리 및 추적 시스템은 민감한 생물학적 물질의 정확한 취급과 적시 배송을 보장하는 소프트웨어 분야에서 선두를 달리고 있습니다. 재고 관리 소프트웨어 또한 보관의 최적화와 낭비를 줄여주어 인기를 끌고 있습니다. 환자 데이터 통합 및 컴플라이언스 솔루션을 포함한 데이터 관리 하위 부문은 규제 요건과 원활한 데이터 교환의 필요성으로 인해 근소한 차이로 그 뒤를 잇고 있습니다. 클라우드 기반 솔루션은 확장성과 기존 시스템과의 통합 용이성으로 인해 선호되는 선택지로 떠오르고 있지만, 데이터 보안을 우선시하는 조직에게는 On-Premise 솔루션이 여전히 중요합니다. 하이브리드 모델은 유연성과 제어의 균형 잡힌 접근 방식을 제공하여 인기를 끌고 있습니다. 예측 분석 및 AI 기반 최적화 도구에 대한 투자가 증가하면서 의사결정과 업무 효율성이 향상되고 있습니다. 엔드 투 엔드 가시성과 추적 가능성에 중점을 두고 공급망 전반의 품질과 규정 준수를 보장하는 것이 가장 중요합니다.

시장 세분화
유형 전사적 자원 관리(ERP), 제조 실행 시스템(MES), 공급망 관리(SCM), 고객 관계 관리(CRM), 실험실 정보 관리 시스템(LIMS), 품질관리 시스템(QMS)
제품 소프트웨어 플랫폼, 데이터 관리 툴, 애널리틱스 솔루션, 자동화 소프트웨어, 클라우드 기반 솔루션, 모바일 애플리케이션
서비스 컨설팅, 구현, 통합, 유지관리, 트레이닝, 지원
기술 블록체인, 인공지능(AI), 머신러닝, 사물인터넷(IoT), 빅데이터 분석, 클라우드 컴퓨팅
컴포넌트 소프트웨어, 하드웨어, 서비스
용도 세포 치료, 유전자 치료, 맞춤형 의료, 임상시험, 바이오뱅크, 연구개발
프로세스 제조, 물류, 품질관리, 재고 관리, 유통, 컴플라이언스 관리
전개 On-Premise, 클라우드 기반, 하이브리드
최종사용자 제약회사, 바이오테크놀러지 기업, 연구기관, 제조 수탁 기관(CMO), 의료 제공자
스테이지 전임상, 임상, 상업, 시판 후 조사

시장 현황

세포 및 유전자 치료 공급망 소프트웨어 시장은 혁신적인 가격 책정 모델과 전략적 제품 출시로 시장 점유율이 역동적으로 변화하고 있습니다. 기업들은 새로운 기회를 포착하고 효율적인 공급망 솔루션에 대한 수요 증가에 대응하기 위해 적극적으로 포트폴리오를 다각화하고 있습니다. 이러한 추세는 특히 북미와 유럽에서 두드러지게 나타나고 있으며, 기술의 발전과 정교한 소프트웨어 솔루션의 통합이 시장의 판도를 바꾸고 있습니다. 업무 효율성 향상과 엄격한 업계 표준을 준수하는 데 중점을 두고 있습니다. 경쟁 벤치마킹에 따르면, 주요 업체들이 시장 지위를 유지하기 위해 끊임없는 기술 혁신을 하고 있으며, 경쟁 환경은 매우 치열합니다. 시장의 성공을 위해서는 진화하는 세계 표준을 준수하는 것이 필수적이기 때문에 규제의 영향도 큽니다. 경쟁 환경은 시장 도달 범위와 기술력 확대를 위한 전략적 제휴와 합병으로 특징지어집니다. 북미와 유럽의 규제 프레임워크는 혁신과 성장을 가속하는 환경을 조성하고 시장의 역동성을 형성하는 데 매우 중요합니다. 디지털 기술의 발전과 공급망 업무의 복잡성으로 인해 시장은 앞으로도 계속 확대될 전망입니다.

주요 트렌드와 촉진요인:

세포 및 유전자 치료 공급망 소프트웨어 시장은 기술 발전과 개인 맞춤형 의료의 도입 확대에 따라 급속한 확장을 경험하고 있습니다. 치료법이 복잡해짐에 따라 복잡한 공급망을 관리할 수 있는 강력한 소프트웨어 솔루션에 대한 수요가 증가하고 있습니다. 주요 동향으로는 인공지능과 머신러닝의 통합을 통한 예측 분석 강화, 적시 납품 및 품질 관리 보장 등을 들 수 있습니다. 또한, 규제 준수에 대한 중요성이 높아지면서 엔드투엔드 추적성과 투명성을 제공하는 소프트웨어의 필요성이 더욱 커지고 있습니다. 임상시험의 분산화도 중요한 트렌드이며, 다양한 물류 요구사항에 대응할 수 있는 민첩한 공급망 솔루션이 필요합니다. 또한, 바이오 의약품에 대한 투자 급증, 온도 변화에 민감한 제품의 효율적인 관리 필요성 등도 촉진요인으로 작용하고 있습니다. 진화하는 산업의 요구에 대응하고 확장성과 유연성을 제공하는 클라우드 기반 플랫폼 개발에는 기회가 넘쳐나고 있습니다. 데이터 보안과 상호운용성을 혁신하는 기업들은 빠르게 성장하는 이 시장의 중요한 수요에 대응하고 경쟁력을 확보할 수 있는 태세를 갖추고 있습니다.

억제와 과제:

세포 및 유전자 치료 공급망 소프트웨어 시장에는 몇 가지 중요한 시장 성장 억제요인과 과제가 있습니다. 주요 장애물은 복잡한 규제 환경과 다양하고 진화하는 국제 표준을 준수해야 한다는 점입니다. 이러한 복잡성은 종종 운영 비용 증가와 지연을 초래합니다. 또한, 소프트웨어와 생명공학 용도에 정통한 숙련된 전문가가 부족하여 도입 및 구현 속도를 제한하고 있는 것도 시장의 걸림돌이 되고 있습니다. 또 다른 문제는 고급 소프트웨어 솔루션에 필요한 초기 투자비용이 비싸다는 점으로 중소기업 시장 진입을 가로막고 있다는 점입니다. 새로운 기술과 기존 레거시 시스템과의 통합은 더 많은 어려움을 수반하며, 종종 호환성 문제와 비효율성을 초래합니다. 또한, 환자 정보는 기밀성이 높기 때문에 강력한 사이버 보안 대책이 필요합니다. 마지막으로, 기술 발전 속도가 빠르기 때문에 지속적인 업데이트와 유지보수가 필요하며, 이는 기업의 재정적, 업무적 부담을 증가시킵니다. 이러한 요인들은 총체적으로 시장 확대에 큰 도전이 되고 있습니다.

주요 기업

Vineti,TrakCel,Be The Match BioTherapies,SAP Advanced Track and Trace for Pharmaceuticals,L7 Informatics,BioLife Solutions,Autolomous,Cytiva,Ori Biotech,CellChain,Thermo Fisher Scientific,Bluechiip,BioCision,Savana,RoosterBio

목차

제1장 세포 및 유전자 치료 공급망 소프트웨어 시장 개요

  • 조사 목적
  • 세포 및 유전자 치료 공급망 소프트웨어 시장 정의와 조사 범위
  • 보고서 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 프리미엄 인사이트

제4장 세포 및 유전자 치료 공급망 소프트웨어 시장 전망

  • 세포 및 유전자 치료 공급망 소프트웨어 시장 세분화
  • 시장 역학
  • Porter의 Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 세포 및 유전자 치료 공급망 소프트웨어 시장 전략

  • 주요 시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 세포 및 유전자 치료 공급망 소프트웨어 시장 규모

  • 세포 및 유전자 치료 공급망 소프트웨어 시장 규모 : 밸류체인별
  • 세포 및 유전자 치료 공급망 소프트웨어 시장 규모 : 수량 기준

제7장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 유형별

  • 시장 개요
  • 전사적 자원 관리(ERP)
  • 제조 실행 시스템(MES)
  • 공급망 관리(SCM)
  • 고객 관계 관리(CRM)
  • 실험실 정보 관리 시스템(LIMS)
  • 품질관리 시스템(QMS)
  • 기타

제8장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 제품별

  • 시장 개요
  • 소프트웨어 플랫폼
  • 데이터 관리 툴
  • 분석 솔루션
  • 자동화 소프트웨어
  • 클라우드 기반 솔루션
  • 모바일 애플리케이션
  • 기타

제9장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 서비스별

  • 시장 개요
  • 컨설팅
  • 구현
  • 통합
  • 유지관리
  • 트레이닝
  • 지원
  • 기타

제10장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 기술별

  • 시장 개요
  • 블록체인
  • 인공지능
  • 머신러닝
  • 사물인터넷(IoT)
  • 빅데이터 분석
  • 클라우드·컴퓨팅
  • 기타

제11장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 컴포넌트별

  • 시장 개요
  • 소프트웨어
  • 하드웨어
  • 서비스
  • 기타

제12장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 용도별

  • 시장 개요
  • 세포치료
  • 유전자 치료
  • 맞춤형 의료
  • 임상시험
  • 바이오뱅크
  • 연구개발
  • 기타

제13장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 프로세스별

  • 시장 개요
  • 제조
  • 물류
  • 품질관리
  • 재고 관리
  • 유통
  • 컴플라이언스 관리
  • 기타

제14장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 전개 형태별

  • 시장 개요
  • On-Premise
  • 클라우드 기반
  • 하이브리드
  • 기타

제15장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 최종사용자별

  • 시장 개요
  • 제약회사
  • 바이오테크놀러지 기업
  • 연구기관
  • 제조 수탁 기관(CMO)
  • 의료 제공자
  • 기타

제16장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 스테이지별

  • 시장 개요
  • 전임상
  • 임상
  • 상업
  • 시판 후 조사
  • 기타

제17장 세포 및 유전자 치료 공급망 소프트웨어 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제19장 기업 개요

  • Vineti
  • TrakCel
  • Be The Match BioTherapies
  • SAP Advanced Track and Trace for Pharmaceuticals
  • L7 Informatics
  • BioLife Solutions
  • Autolomous
  • Cytiva
  • Ori Biotech
  • CellChain
  • Thermo Fisher Scientific
  • Bluechiip
  • BioCision
  • Savana
  • RoosterBio
LSH

Cell and Gene Therapy Supply Chain Software Market is anticipated to expand from $458.2 million in 2024 to $2,028.1 million by 2034, growing at a CAGR of approximately 16%. The Cell and Gene Therapy Supply Chain Software Market encompasses digital solutions designed to manage the complex logistics of advanced therapies. These platforms ensure compliance, traceability, and efficiency from manufacturing to patient delivery. As the cell and gene therapy sector expands, demand for robust, secure, and scalable software solutions is intensifying, driven by the need for precision in handling personalized medicine logistics, regulatory adherence, and real-time data management.

The Cell and Gene Therapy Supply Chain Software Market is experiencing robust growth, fueled by the increased adoption of personalized medicine and advanced therapies. The software segment, particularly logistics management and tracking systems, leads in performance, ensuring precise handling and timely delivery of sensitive biological materials. Inventory management software is also gaining traction, optimizing storage and reducing waste. The data management sub-segment, encompassing patient data integration and compliance solutions, follows closely, driven by regulatory demands and the necessity for seamless data exchange. Cloud-based solutions are emerging as a preferred choice due to their scalability and ease of integration with existing systems, while on-premise solutions remain critical for organizations prioritizing data security. Hybrid models are gaining popularity, offering a balanced approach to flexibility and control. Investments in predictive analytics and AI-driven optimization tools are rising, enhancing decision-making and operational efficiency. The focus on end-to-end visibility and traceability is paramount, ensuring quality and compliance throughout the supply chain.

Market Segmentation
TypeEnterprise Resource Planning (ERP), Manufacturing Execution Systems (MES), Supply Chain Management (SCM), Customer Relationship Management (CRM), Laboratory Information Management Systems (LIMS), Quality Management Systems (QMS)
ProductSoftware Platforms, Data Management Tools, Analytics Solutions, Automation Software, Cloud-based Solutions, Mobile Applications
ServicesConsulting, Implementation, Integration, Maintenance, Training, Support
TechnologyBlockchain, Artificial Intelligence, Machine Learning, Internet of Things (IoT), Big Data Analytics, Cloud Computing
ComponentSoftware, Hardware, Services
ApplicationCell Therapy, Gene Therapy, Personalized Medicine, Clinical Trials, Biobanking, Research and Development
ProcessManufacturing, Logistics, Quality Control, Inventory Management, Distribution, Compliance Management
DeploymentOn-premise, Cloud-based, Hybrid
End UserPharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Manufacturing Organizations (CMOs), Healthcare Providers
StagePre-clinical, Clinical, Commercial, Post-market Surveillance

Market Snapshot:

The Cell and Gene Therapy Supply Chain Software Market is witnessing dynamic shifts in market share driven by innovative pricing models and strategic product launches. Companies are actively diversifying their portfolios to capture emerging opportunities and meet the growing demand for efficient supply chain solutions. This trend is particularly pronounced in North America and Europe, where technological advancements and the integration of sophisticated software solutions are reshaping the landscape. The focus remains on enhancing operational efficiency and ensuring compliance with stringent industry standards. Competition benchmarking reveals a highly competitive environment, with key players continuously innovating to maintain their market positions. Regulatory influences are significant, as compliance with evolving global standards is crucial for market success. The competitive landscape is characterized by strategic collaborations and mergers aimed at expanding market reach and technological capabilities. The regulatory frameworks in North America and Europe are pivotal in shaping market dynamics, fostering an environment conducive to technological innovation and growth. The market is poised for continued expansion, driven by advancements in digital technologies and the increasing complexity of supply chain operations.

Geographical Overview:

The Cell and Gene Therapy Supply Chain Software Market is witnessing robust growth across various regions, each exhibiting unique characteristics. North America is at the forefront, propelled by advanced healthcare infrastructure and substantial investments in biotechnology. The region's focus on innovation and regulatory support further accelerates market expansion. Europe is closely following, with strong emphasis on research and development, fostering a favorable environment for market growth. The Asia Pacific region is rapidly emerging as a lucrative market, driven by technological advancements and increasing investments in healthcare technologies. Countries like China and India are spearheading this growth, supported by government initiatives and expanding biotech industries. Latin America and the Middle East & Africa are gaining traction as emerging markets. In Latin America, increasing healthcare expenditure and investments in biotechnology are driving market development, while the Middle East & Africa are recognizing the potential of cell and gene therapy in enhancing healthcare outcomes.

Key Trends and Drivers:

The Cell and Gene Therapy Supply Chain Software Market is experiencing rapid expansion, driven by technological advancements and increased adoption of personalized medicine. As therapies become more complex, there is a heightened demand for robust software solutions to manage intricate supply chains. Key trends include the integration of artificial intelligence and machine learning to enhance predictive analytics, ensuring timely delivery and quality control. Furthermore, the growing emphasis on regulatory compliance is propelling the need for software that provides end-to-end traceability and transparency. The rise of decentralized clinical trials is another significant trend, necessitating agile supply chain solutions to accommodate diverse logistical requirements. Drivers also include the surge in biopharmaceutical investments and the need for efficient management of temperature-sensitive products. Opportunities abound in the development of cloud-based platforms that offer scalability and flexibility, catering to evolving industry needs. Companies that innovate in data security and interoperability are poised to gain a competitive edge, addressing the critical demands of this burgeoning market.

Restraints and Challenges:

The Cell and Gene Therapy Supply Chain Software Market encounters several significant restraints and challenges. A primary obstacle is the intricate regulatory environment, which necessitates compliance with diverse and evolving international standards. This complexity often results in increased operational costs and delays. Additionally, the market is hampered by the shortage of skilled professionals proficient in both software and biotechnological applications, which limits the speed of adoption and implementation. Another challenge is the high initial investment required for advanced software solutions, deterring smaller enterprises from entering the market. The integration of new technologies with existing legacy systems presents further difficulties, often resulting in compatibility issues and inefficiencies. Moreover, data security concerns are paramount, as the sensitive nature of patient information requires robust cybersecurity measures. Lastly, the rapid pace of technological advancements necessitates continuous updates and maintenance, adding to the financial and operational burden on companies. These factors collectively pose significant challenges to market expansion.

Key Players:

Vineti, TrakCel, Be The Match BioTherapies, SAP Advanced Track and Trace for Pharmaceuticals, L7 Informatics, BioLife Solutions, Autolomous, Cytiva, Ori Biotech, CellChain, Thermo Fisher Scientific, Bluechiip, BioCision, Savana, RoosterBio

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cell and Gene Therapy Supply Chain Software Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Cell and Gene Therapy Supply Chain Software Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by End User
  • 2.12 Key Highlights of the Market, by Stage
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by End User
  • 3.11 Market Attractiveness Analysis, by Stage
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Cell and Gene Therapy Supply Chain Software Market Outlook

  • 4.1 Cell and Gene Therapy Supply Chain Software Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Cell and Gene Therapy Supply Chain Software Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Cell and Gene Therapy Supply Chain Software Market Size

  • 6.1 Cell and Gene Therapy Supply Chain Software Market Size, by Value
  • 6.2 Cell and Gene Therapy Supply Chain Software Market Size, by Volume

7: Cell and Gene Therapy Supply Chain Software Market, by Type

  • 7.1 Market Overview
  • 7.2 Enterprise Resource Planning (ERP)
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Manufacturing Execution Systems (MES)
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Supply Chain Management (SCM)
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Customer Relationship Management (CRM)
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Laboratory Information Management Systems (LIMS)
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Quality Management Systems (QMS)
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Others
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region

8: Cell and Gene Therapy Supply Chain Software Market, by Product

  • 8.1 Market Overview
  • 8.2 Software Platforms
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Data Management Tools
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Analytics Solutions
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Automation Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Cloud-based Solutions
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Mobile Applications
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Others
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region

9: Cell and Gene Therapy Supply Chain Software Market, by Services

  • 9.1 Market Overview
  • 9.2 Consulting
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Implementation
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Integration
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Maintenance
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Training
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Support
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Cell and Gene Therapy Supply Chain Software Market, by Technology

  • 10.1 Market Overview
  • 10.2 Blockchain
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Artificial Intelligence
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Machine Learning
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Internet of Things (IoT)
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Big Data Analytics
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Cloud Computing
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Cell and Gene Therapy Supply Chain Software Market, by Component

  • 11.1 Market Overview
  • 11.2 Software
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Hardware
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Cell and Gene Therapy Supply Chain Software Market, by Application

  • 12.1 Market Overview
  • 12.2 Cell Therapy
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Gene Therapy
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Personalized Medicine
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Clinical Trials
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Biobanking
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Research and Development
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Others
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region

13: Cell and Gene Therapy Supply Chain Software Market, by Process

  • 13.1 Market Overview
  • 13.2 Manufacturing
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Logistics
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Quality Control
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Inventory Management
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Distribution
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Compliance Management
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Cell and Gene Therapy Supply Chain Software Market, by Deployment

  • 14.1 Market Overview
  • 14.2 On-premise
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Cloud-based
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Hybrid
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Cell and Gene Therapy Supply Chain Software Market, by End User

  • 15.1 Market Overview
  • 15.2 Pharmaceutical Companies
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Biotechnology Firms
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Research Institutes
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Contract Manufacturing Organizations (CMOs)
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Healthcare Providers
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region
  • 15.7 Others
    • 15.7.1 Key Market Trends & Opportunity Analysis
    • 15.7.2 Market Size and Forecast, by Region

16: Cell and Gene Therapy Supply Chain Software Market, by Stage

  • 16.1 Market Overview
  • 16.2 Pre-clinical
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Clinical
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Commercial
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Post-market Surveillance
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Cell and Gene Therapy Supply Chain Software Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Component
    • 17.2.7 North America Market Size and Forecast, by Application
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by End User
    • 17.2.11 North America Market Size and Forecast, by Stage
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Component
      • 17.2.9.6 United States Market Size and Forecast, by Application
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by End User
      • 17.2.9.10 United States Market Size and Forecast, by Stage
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Component
      • 17.2.10.6 Canada Market Size and Forecast, by Application
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by End User
      • 17.2.10.10 Canada Market Size and Forecast, by Stage
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Component
    • 17.3.7 Europe Market Size and Forecast, by Application
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by End User
    • 17.3.11 Europe Market Size and Forecast, by Stage
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Component
      • 17.3.10.6 Germany Market Size and Forecast, by Application
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by End User
      • 17.3.10.10 Germany Market Size and Forecast, by Stage
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Component
      • 17.3.11.6 France Market Size and Forecast, by Application
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by End User
      • 17.3.11.10 France Market Size and Forecast, by Stage
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Component
      • 17.3.12.6 Spain Market Size and Forecast, by Application
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by End User
      • 17.3.12.10 Spain Market Size and Forecast, by Stage
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Component
      • 17.3.13.6 Italy Market Size and Forecast, by Application
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by End User
      • 17.3.13.10 Italy Market Size and Forecast, by Stage
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Component
      • 17.3.14.6 Netherlands Market Size and Forecast, by Application
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by End User
      • 17.3.14.10 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Component
      • 17.3.15.6 Sweden Market Size and Forecast, by Application
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by End User
      • 17.3.15.10 Sweden Market Size and Forecast, by Stage
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Component
      • 17.3.16.6 Switzerland Market Size and Forecast, by Application
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by End User
      • 17.3.16.10 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Component
      • 17.3.17.6 Denmark Market Size and Forecast, by Application
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by End User
      • 17.3.17.10 Denmark Market Size and Forecast, by Stage
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Component
      • 17.3.18.6 Finland Market Size and Forecast, by Application
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by End User
      • 17.3.18.10 Finland Market Size and Forecast, by Stage
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Component
      • 17.3.19.6 Russia Market Size and Forecast, by Application
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by End User
      • 17.3.19.10 Russia Market Size and Forecast, by Stage
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Component
      • 17.4.9.6 China Market Size and Forecast, by Application
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by End User
      • 17.4.9.10 China Market Size and Forecast, by Stage
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Component
      • 17.4.10.6 India Market Size and Forecast, by Application
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by End User
      • 17.4.10.10 India Market Size and Forecast, by Stage
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Component
      • 17.4.11.6 Japan Market Size and Forecast, by Application
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by End User
      • 17.4.11.10 Japan Market Size and Forecast, by Stage
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Component
      • 17.4.12.6 South Korea Market Size and Forecast, by Application
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by End User
      • 17.4.12.10 South Korea Market Size and Forecast, by Stage
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Component
      • 17.4.13.6 Australia Market Size and Forecast, by Application
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by End User
      • 17.4.13.10 Australia Market Size and Forecast, by Stage
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Component
      • 17.4.14.6 Singapore Market Size and Forecast, by Application
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by End User
      • 17.4.14.10 Singapore Market Size and Forecast, by Stage
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Component
      • 17.4.15.6 Indonesia Market Size and Forecast, by Application
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by End User
      • 17.4.15.10 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Component
      • 17.4.16.6 Taiwan Market Size and Forecast, by Application
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by End User
      • 17.4.16.10 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Component
      • 17.4.17.6 Malaysia Market Size and Forecast, by Application
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by End User
      • 17.4.17.10 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Component
    • 17.5.7 Latin America Market Size and Forecast, by Application
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by End User
    • 17.5.11 Latin America Market Size and Forecast, by Stage
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Component
      • 17.5.9.6 Brazil Market Size and Forecast, by Application
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by End User
      • 17.5.9.10 Brazil Market Size and Forecast, by Stage
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Component
      • 17.5.10.6 Mexico Market Size and Forecast, by Application
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by End User
      • 17.5.10.10 Mexico Market Size and Forecast, by Stage
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Component
      • 17.5.11.6 Argentina Market Size and Forecast, by Application
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by End User
      • 17.5.11.10 Argentina Market Size and Forecast, by Stage
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Component
      • 17.6.10.6 UAE Market Size and Forecast, by Application
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by End User
      • 17.6.10.10 UAE Market Size and Forecast, by Stage
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Component
      • 17.6.11.6 South Africa Market Size and Forecast, by Application
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by End User
      • 17.6.11.10 South Africa Market Size and Forecast, by Stage
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Vineti
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 TrakCel
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Be The Match BioTherapies
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 SAP Advanced Track and Trace for Pharmaceuticals
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 L7 Informatics
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 BioLife Solutions
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Autolomous
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Cytiva
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Ori Biotech
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 CellChain
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Thermo Fisher Scientific
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Bluechiip
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 BioCision
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Savana
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 RoosterBio
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제